16.04.2012
- Indian drugmaker Piramal Healthcare sees revenue potential of $1.5 billion from its new florbetaben molecule, a possible Alzheimer's treatment acquired by the company in a deal...
05.04.2012
- A raft of new medicines pushed U.S. spending on drugs modestly higher last year, but the gains were curbed by weak prescription use as Americans avoided doctor visits, according to...
02.04.2012
- In a nondescript suburb south of London, tucked away behind a big hospital, Paul Workman and fellow scientists are celebrating victory in the "World Cup" of cancer drug research...
15.03.2012
- German chemicals and drugs group Bayer expects higher profit margins and sales at its healthcare division over the next three years, where product launches are set to boost...
12.03.2012
- Bayer is sounding out its debt financing options with banks to prepare for takeover opportunities such as one that may arise from Pfizer's mooted exit from veterinary medicine...
25.01.2012
- Down South - Atlanta has a healthy biosciences community with a rich mix of pharmaceutical, medical devices, diagnostic and medical supply companies; contract laboratory...
22.12.2011
- GlaxoSmithKline executive German Pasteris is in charge of an Alzheimer's treatment that is years from reaching the market, if it ever does. But he already wants to make sure the...
03.11.2011
- Viiv Healthcare, a GlaxoSmithKline and Pfizer joint venture, will start manufacturing HIV medicines in Russia in partnership with local drugmaker Binnopharm. Agreeing a local...
